← Back to Search

Physical activity for Sleep Apnea (RAP Trial)

N/A
Waitlist Available
Led By Jean-Louis Pépin, Pr MD PhD
Research Sponsored by AGIR à Dom
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up to baseline at 12 weeks
Awards & highlights

RAP Trial Summary

Investigators hypothesize that CPAP treatment for suppressing OSAS in combination with a physical activity program will optimize 24-hour blood pressure control in patients with OSA-related resistant hypertension.

Eligible Conditions
  • Sleep Apnea
  • Hypertension

RAP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~to baseline at 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and to baseline at 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Systolic arterial blood pressure assessed by 24-hours home blood pressure monitoring
Secondary outcome measures
Change in physical activity : Metabolic Equivalents (METS)
Change in physical activity : Number of steps per day
Change in physical activity: number of hour per day of physical activity
+4 more

RAP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Physical activityExperimental Treatment1 Intervention
Obstructive sleep apnea and resistant hypertension controlled + physical activity
Group II: Control GroupActive Control1 Intervention
Obstructive sleep apnea and resistant hypertension controlled

Find a Location

Who is running the clinical trial?

University Hospital, GrenobleOTHER
794 Previous Clinical Trials
250,017 Total Patients Enrolled
12 Trials studying Sleep Apnea
2,693 Patients Enrolled for Sleep Apnea
AGIR à DomLead Sponsor
34 Previous Clinical Trials
5,000 Total Patients Enrolled
4 Trials studying Sleep Apnea
245 Patients Enrolled for Sleep Apnea
Jean-Louis Pépin, Pr MD PhDPrincipal InvestigatorLaboratoire EFCR, CHU de Grenoble, 38043, Grenoble, France
1 Previous Clinical Trials
50 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Apr 2025